Guggenheim raises Gentex stock price target to $26 on potential synergies

Published 17/07/2025, 13:36
Guggenheim raises Gentex stock price target to $26 on potential synergies

Investing.com - Guggenheim has raised its price target on Gentex (NASDAQ:GNTX) to $26.00 from $25.00 while maintaining a Buy rating on the stock. According to InvestingPro data, the company currently trades at $23.21, with analysis indicating the stock is undervalued based on Fair Value metrics.

The research firm cited potential synergies from the VOXX acquisition as a key factor in its decision to increase the price target. Guggenheim’s new target is based on a 15.5x multiple on its 2026 earnings per share estimate of $1.74, up from the previous 15.0x multiple. The company’s strong financial health is evident in its robust balance sheet, with more cash than debt and liquid assets exceeding short-term obligations.

Guggenheim noted that Gentex shares currently trade at approximately 14.3x its 2025 estimated earnings per share, which is below the 5-year average of 15.0x. The firm believes a multiple in line with historical averages is appropriate given the current market conditions. This valuation perspective is supported by three analysts recently revising their earnings estimates upward, while the company maintains its 23-year track record of consistent dividend payments.

The analysis balances cyclically depressed production resulting from tariffs and the VOXX acquisition against potential benefits including 2026 synergies, possible dimmable surfaces business wins, and favorable capital deployment opportunities.

Guggenheim shifted its valuation focus to 2026 earnings, stating this approach better incorporates the potential synergies expected from the VOXX merger and acquisition activity.

In other recent news, Gentex Corporation reported its first-quarter 2025 earnings, revealing a slight miss on earnings per share (EPS) expectations, with an EPS of $0.42 compared to the forecasted $0.43. Revenue for the quarter also fell short, coming in at $576.8 million against the expected $578.68 million. In addition, Gentex announced a strategic move with the approval of a 40 million share buyback plan, reflecting confidence in the company’s long-term growth potential. Meanwhile, the company held its Annual Meeting of Shareholders, where eight directors were elected and Ernst & Young LLP was ratified as the auditors for the fiscal year.

JPMorgan recently adjusted Gentex’s price target to $26.00 from $27.00, maintaining a Neutral rating, following a reduction in the company’s full-year revenue forecast. The company faces challenges due to trade tensions with China, which have led to halted orders from Chinese customers. Despite these hurdles, Gentex completed a strategic merger with VOXX, expected to contribute significantly to the company’s revenue. The company is also expanding its product offerings, including new driver monitoring systems, indicating a focus on innovation amid the current market conditions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.